Learn more

ANHUI LIANCHUANG BIOLOGICAL MEDICINE CO LTD

Overview
  • Total Patents
    16
  • GoodIP Patent Rank
    105,663
  • Filing trend
    ⇧ 66.0%
About

ANHUI LIANCHUANG BIOLOGICAL MEDICINE CO LTD has a total of 16 patent applications. It increased the IP activity by 66.0%. Its first patent ever was published in 2016. It filed its patents most often in China. Its main competitors in its focus markets biotechnology, measurement and organic fine chemistry are ZHEJIANG ZOYUN BIOTECHNOLOGY CO LTD, MICROBIX BIOSYSTEMS INC and IMMCO DIAGNOSTICS INC.

Patent filings in countries

World map showing ANHUI LIANCHUANG BIOLOGICAL MEDICINE CO LTDs patent filings in countries
# Country Total Patents
#1 China 16

Patent filings per year

Chart showing ANHUI LIANCHUANG BIOLOGICAL MEDICINE CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wu Qihua 16
#2 Ge Depei 16
#3 Chen Haibing 7
#4 Li Qiang 5
#5 Liu Tao 5
#6 Shao Guangqing 4
#7 Wang Haitao 4
#8 Hong Jiong 3
#9 Zhang Zhongtao 1

Latest patents

Publication Filing date Title
CN111983055A Method for separating and measuring rivaroxaban intermediate related substances by using HPLC (high performance liquid chromatography)
CN111983054A Method for separating and measuring related substances of empagliflozin intermediate by using HPLC (high performance liquid chromatography)
CN111983056A Method for separating and measuring related substances of tofacitinib intermediate by using HPLC (high performance liquid chromatography)
CN111999400A Method for separating and determining impurities of bulk drugs of baricitinib by using HPLC (high performance liquid chromatography)
CN111253346A Synthetic method for preparing empagliflozin intermediate
CN111411116A Ketoreductase, nucleic acid, recombinant expression plasmid and strain, and application in synthesis of Laolatinib intermediate
CN109374782A A method of with the related substance of the net bulk pharmaceutical chemicals of HPLC separation determination Yi Palie
CN109374784A A method of with the related substance of HPLC separation determination Dapagliflozin bulk pharmaceutical chemicals
CN109374783A A method of with the related substance of HPLC separation determination canagliflozin bulk pharmaceutical chemicals
CN109295020A Ketoreductase and its application in synthesis (1S) -2- chloro- 1- (3,4- difluorophenyl) ethyl alcohol
CN109295021A Ketoreductase and its application in bis- (trifluoromethyl) benzyl carbinols of asymmetric syntheses R-3,5-
CN108018026A A kind of dust inhibitor and preparation method thereof
CN107904269A A kind of method that engineering strain conversion prepares (S) (+) 3 hydroxyl tetrahydrofuran
CN108220261A Ketoreductase, nucleic acid, recombinant expression carrier, recombinant strains and application
CN106053665A Method for measuring related substances in ipragliflozin proline bulk pharmaceutical chemicals through HPLC separation
CN105777719A Synthesis method of Daclatasvir